Nonetheless, our findings suggesting little evidence of association of genetically proxied ANGPTL3, APOC3, CETP, and PCSK9 inhibition with cancer risk may help to deprioritize further evaluation of these proteins as intervention targets for cancer prevention. Here, APOC3 is linked to cancer.